The Beauty Health Company (SKIN) reported Q4 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $98.1 million versus the consensus estimate of $94.73 million.
GUIDANCE:
The Beauty Health Company sees FY2023 EPS of $450.00-$470.00, versus the consensus of $439.60.